SAU · 4005.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:11 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
National Medical Care Company’s forward annual dividend is SAR 3.00 per share, paid annual. The forward yield is 2.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
National Medical Care Company’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of SAR 1.99. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow National Medical Care Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
National Medical Care Company is dedicated to the comprehensive establishment, ownership, operation, and maintenance of healthcare facilities across the Kingdom of Saudi Arabia. Its substantial portfolio includes the 325-bed Riyadh Care Hospital, the 459-bed National Hospital, the Family Health Care Center, and the Care Company for Pharmaceutical and Medical Distribution. In addition to these institutional services, the company also provides home healthcare. Founded in 2003, it is headquartered in Riyadh, Saudi Arabia.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SAR 398.00M+1.83% vs estimate |
| Q1 2025 | May 12, 2025 | SAR 1.91+10.4% vs estimate | SAR 385.32M-2.75% vs estimate |
|---|
| Q4 2024 | Feb 25, 2025 | SAR 1.95+21.12% vs estimate | SAR 372.54M+5.61% vs estimate |
|---|
| Q3 2024 | Oct 21, 2024 | SAR 1.34-13.55% vs estimate | SAR 325.77M-1.8% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 21.43-SAR 0.07 (-0.33%)
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
SAR 12.97+SAR 0.27 (+2.13%)
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
SAR 23.65-SAR 0.43 (-1.79%)
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
SAR 22.00+SAR 0.02 (+0.09%)
Naba Alsaha Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 28.92% below the high.
